Traders should monitor for incremental ATM sales, which could exert downward pressure on the stock price given its low float and thin trading volume. The significant gap between the valuation used for the shelf ($1.25) and current trading price ($0.5180) suggests market skepticism, increasing downside risk if sales proceed.
Price Chart
Executive Summary
AIM ImmunoTech Inc. amended its Form S-3 shelf registration to increase the maximum aggregate offering price of its common stock to $3,409,174 under an at-the-market (ATM) sales agreement with Maxim Group LLC. The company has already sold approximately $2.29 million under this shelf and may sell up to an additional $1.12 million. The filing revises prior prospectus supplements but does not indicate immediate fundraising.
Key Facts
- AIM ImmunoTech increased the maximum aggregate offering under its ATM program to $3,409,174.
- The public float as of April 10, 2026, was approximately $10,227,521, with non-affiliate shares valued at $1.25 per share (Feb 13 price), though the stock traded at $0.5180 on April 9, 2026.
- The company has already sold ~$2.289 million under this shelf and is eligible to sell up to $1.12 million more within the 12-month period limit (one-third of public float).
- Sales are conducted under an Equity Distribution Agreement with Maxim Group LLC, which receives up to 3% commission on gross proceeds.
- No funds are held in escrow; sales are made on a best-efforts basis in the open market.
Financial Impact
Potential dilution of up to $1.12 million in additional shares if fully utilized, with total shelf capacity now at $3.41 million. The stock trades at a significant discount (~58%) to the valuation used for the one-third public float calculation.
Risk Factors
- Dilution risk from future ATM sales, especially in a low-volume, low-float stock.
- Downward price pressure due to continuous offerings at potentially depressed market prices.
- Market perception of desperation due to reliance on small-scale, repeated ATM offerings.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 424B5 Filing (Primary) | 0001493152-26-016176 |
| Document: 0001493152-26-016176-index-headers.html | 0001493152-26-016176 |
| Document: 0001493152-26-016176-index.html | 0001493152-26-016176 |
| Document: 0001493152-26-016176.txt | 0001493152-26-016176 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 30, 2026 25d ago | DEF 14A | $0.1877 | awaiting T+20 | — | $0.1600 (−14.76%) |
Sep 22, 2026 4w ago | Press Release | $0.2156 $0.1662 | ▼ −22.91% | ▼ −22.35% | $0.1600 (−25.79%) |
Sep 14, 2026 5w ago | 8-K | $0.2100 | awaiting T+20 | — | $0.1600 (+23.81%) |
Aug 11, 2026 10w ago | 8-K | $0.2500 $0.2332 | ▼ −6.72% | ▼ −5.66% | $0.1600 (−36.00%) |
Aug 10, 2026 10w ago | 8-K | $0.2630 | awaiting T+20 | — | $0.1600 (+39.16%) |
Aug 10, 2026 10w ago | Press Release | $0.2630 | awaiting T+20 | — | $0.1600 (+39.16%) |
Aug 5, 2026 11w ago | 8-K | $0.2800 $0.2346 | ▼ −16.21% | ▼ −15.61% | $0.1600 (−42.86%) |
Aug 3, 2026 11w ago | Press Release | $0.2600 $0.2260 | ▼ −13.08% | ▼ −14.31% | $0.1600 (−38.46%) |
Jun 24, 2026 17w ago | EFFECT | $0.3740 $0.2534 | ▲ +32.25% | ▲ +34.18% | $0.1600 (+57.22%) |
Jun 18, 2026 18w ago | S-1 | $0.3799 $0.2730 | ▲ +28.14% | ▲ +28.67% | $0.1600 (+57.88%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers